Company profile
Neuphoria Therapeutics Inc.
NASDAQ:NEUPBiotechnology: Pharmaceutical Preparations
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.